Search Results
Jul 30, 2026, 07:02 ET Piramal Pharma Limited、27年度第1四半期の業績を発表
髄腔内療法：米国の髄腔内バクロフェン市場で首位を維持しました。（出典：IQVIA）注射剤による疼痛管理：製品の供給力を高めるため、サプライヤーと連携しています。 差別化製品およびスペシャリティ製品：ライセンス導入および共同開発を通じて、505(b)(2)製品、複雑かつ差別化されたジェネリック医薬品、ブランド医薬品への投資を継続しました。Piramal Consumer Healthcare（PCH）：
More news about: Piramal Pharma Limited
Jul 30, 2026, 07:00 ET CREATE Medicines Receives Approval to Initiate First-in-Human Phase 1/2 Clinical Trial of In Vivo CAR-T Candidate CRT-402 for Autoimmune Diseases
within the body to deplete autoreactive B cells and drive disease into remission. Because it works in vivo, CRT-402 removes the need for the ex vivo cell manufacturing required by conventional CAR-T therapies, greatly expanding access to this remission-inducing, B cell depleting approach for patients with
More news about: CREATE Medicines, Inc.
Jul 30, 2026, 07:00 ET Hershey Declares Quarterly Dividends
Class B Common Stock. The dividends were declared July 29, 2026, and are payable September 15, 2026, to stockholders of record as of August 14, 2026. It is the 386th consecutive regular dividend on the Common Stock and the 167th consecutive regular dividend on the Class B Common
More news about: The Hershey Company
Jul 30, 2026, 07:00 ET DFIN Reports Second-Quarter 2026 Results
to the most comparable GAAP measures.(b) Defined as net cash provided by operating activities.(c)
More news about: Donnelley Financial LLC
Jul 30, 2026, 07:00 ET International Paper Reports Second Quarter 2026 Results
(b)977(b)
More news about: International Paper
Jul 30, 2026, 07:00 ET CentralReach Continues to Scale as Category Leader in Autism and IDD Care Software, Names Chief Sales Officer Dan Freund
CentralReach's AI-powered clinical and revenue cycle management solutions, launched over the past two years, have collectively helped customers avoid $1.7B in payor clawbacks, cut audit readiness time by 90%, reduce scheduling time by 95%, and save Registered Behavior Technicians (RBTs)
More news about: CentralReach
Jul 30, 2026, 07:00 ET Akido Announces the First AI-Native Health System in the US
Series B was led by Oak HC/FT. For more information, visit
More news about: Akido
Jul 30, 2026, 07:00 ET Basking Biosciences Announces Publication Showing BB-031 Restores Blood Flow in a Microfluidic Model of Acute Ischemic Stroke (AIS)
BB-031 versus placebo in patients with AIS who present within 24 hours of symptom onset. The trial includes two parts. Part A was completed in 2025. Part B will enroll approximately 180 patients. The trial is being conducted at sites across North America and Australia, with additional site activation planned.
More news about: Basking Biosciences Inc.
Jul 30, 2026, 07:00 ET TriNet Announces Second Quarter 2026 Results & Raises FY26 Earnings Guidance
$ 136Adjusted EBITDA (b)$ 128
More news about: TriNet Group, Inc.
Jul 30, 2026, 07:00 ET Terex Reports Second Quarter 2026 Results
$7.9B - $8.2BAdjusted EBITDA1$960M - $1B
More news about: Terex Corporation
Jul 30, 2026, 07:00 ET Hippo Reports Second Quarter 2026 Financial Results
$1.45 - $1.525B$1.65 - $1.7B
More news about: Hippo Holdings Inc.
Jul 30, 2026, 06:59 ET Road Marking Materials Market worth $9.38 billion by 2031 - Exclusive Report by MarketsandMarkets™
alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.Today,
More news about: MarketsandMarkets
Jul 30, 2026, 06:57 ET AEP Reports Second-Quarter 2026 Earnings, Raises Full-Year Guidance
(11)Transmission & Distribution Utilities (b)224
More news about: American Electric Power
Jul 30, 2026, 06:55 ET QUANTA SERVICES REPORTS SECOND QUARTER 2026 RESULTS
6.4 %Corporate and Non-Allocated Costs (b)(359,163)
More news about: Quanta Services, Inc.
Jul 30, 2026, 06:50 ET Labcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 Guidance
137.9Restructuring and other charges (b)
More news about: Labcorp Holdings Inc
Jul 30, 2026, 06:45 ET RPC, Inc. Reports Second Quarter 2026 Financial Results And Declares Regular Quarterly Cash Dividend
$17.8 million, compared to $7.6 million in the prior quarter, and Adjusted diluted EPS was $0.08; Adjusted net income margin was 3.9%. See Appendices B and C for additional detailsAdjusted Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) was $66.0 million, compared to $53.5
More news about: RPC, Inc.
Jul 30, 2026, 06:45 ET Hershey Reports Second-Quarter 2026 Financial Results
- Basic- Class B$ 2.11
More news about: The Hershey Company
Jul 30, 2026, 06:45 ET Life Time Reports Second Quarter 2026 Financial Results
(Gain) loss on sale-leaseback transactions (b)(2,035)
More news about: Life Time Group Holdings, Inc.
Jul 30, 2026, 06:39 ET Piramal Pharma Limited gibt die Ergebnisse für das erste Quartal des Geschäftsjahres 2027 bekannt
Verbesserung der Produktverfügbarkeit. Differenzierte und Spezialprodukte: Fortsetzung der Investitionen in 505(b)(2)-Produkte, komplexe und differenzierte Generika sowie Markenprodukte durch Einlizenzierung und gemeinsame Entwicklung.
More news about: Piramal Pharma Limited
Jul 30, 2026, 06:30 ET PBF Energy Announces Second Quarter 2026 Results, Declares Dividend of $0.275 per Share
42.0Capital expenditures (b)184.0
More news about: PBF Energy Inc.
Jul 30, 2026, 06:30 ET Xenia Hotels & Resorts Reports Second Quarter 2026 Results
sold during the periods presented.b.Excludes non-cash ground rent expense.
More news about: Xenia Hotels & Resorts, Inc.
Jul 30, 2026, 06:00 ET Hyperscale Data Repurposes Bitcoin Treasury Strategy to Accelerate Development of Michigan AI Data Center
as-converted basis. The Divestiture will occur through the voluntary exchange of the Series F Preferred Stock for shares of Class A Common Stock and Class B Common Stock of ACG (collectively, the "ACG Shares"). The Company reminds its stockholders that only those holders of the Series F Preferred Stock
More news about: Hyperscale Data Inc.
Jul 30, 2026, 06:00 ET The Cigna Group Reports Strong Second Quarter 2026 Results, Raises 2026 Outlook
capital. The share repurchase program may be effected through open market purchases in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended, including through Rule 10b5-1 trading plans, or privately negotiated transactions. The program may be suspended or discontinued at any
More news about: The Cigna Group
Jul 30, 2026, 06:00 ET Escalade Reports Second Quarter 2026 Results
1933, as amended, and Rule 175 promulgated thereunder, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and Rule 3b-6 promulgated thereunder. All statements, other than statements of historical fact, are forward-looking statements. These statements relate to our financial
More news about: Escalade, Incorporated
Jul 30, 2026, 06:00 ET Air Products Reports Fiscal 2026 Third Quarter Results
to consolidated results.(B)Segment equity affiliates' income for the nine
More news about: Air Products